Key statistics
On Thursday, Adaptive Biotechnologies Corp (ADPT:NSQ) closed at 11.80, -5.07% below its 52-week high of 12.43, set on Jun 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.88 |
---|---|
High | 11.96 |
Low | 11.48 |
Bid | 11.80 |
Offer | 12.26 |
Previous close | 11.48 |
Average volume | 3.19m |
---|---|
Shares outstanding | 151.92m |
Free float | 144.63m |
P/E (TTM) | -- |
Market cap | 1.79bn USD |
EPS (TTM) | -0.9592 USD |
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
More ▼
- Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
- Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
- Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
- Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
- Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
- Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
- Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
- Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
- Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
- Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
More ▼